James M. Crawford, MD, PhD

Professor and Chair, Department of Pathology and Laboratory Medicine,
Hofstra Northwell School of Medicine

Senior Vice President, Laboratory Services, Northwell Health

Phone: (516) 719-1060
Email: jcrawford1@northwell.edu

About the Investigator

Dr. James Crawford has been with Northwell Health since January 2009. He is a graduate of the Duke University School of Medicine Medical Scientist Training Program (1976-1983) and did his residency training in anatomic pathology and a fellowship in gastrointestinal and hepatic pathology at Brigham and Women’s Hospital (1983-1987).

Dr. Crawford served as fellow in hepatopathology at the Royal Free Hospital, London (1989).  He served as a pathologist at Brigham and Women’s Hospital and as an assistant professor (1987-1995) and associate professor (1995-1996) at Harvard Medical School. He was Associate Professor and Director of Gastrointestinal Pathology at Yale University School of Medicine (1997-1999), as well as Professor and Chair of the Department of Pathology, Immunology and Laboratory Medicine at the University of Florida College of Medicine (1999-2008).

He also has served as president of the Association of Pathology Chairs, chair of the AAMC Council of Academic Societies, president of the Hans Popper Hepatopathology Society and editor-in-chief of Laboratory Investigation, an official journal of the United States and Canadian Academy of Pathology.

Dr. Crawford is a recipient of the 2006 International Academy of Pathology Gold Medal Award, the CAP Resident Forum 2009 Resident Advocacy Award and the 2010 F.K. Mostofi Award of the United States and Canadian Academy of Pathology.

Research Focus

Dr. Crawford’s national advocacy and personal research efforts are focused on advancing the role of pathology and the clinical laboratory in the effective delivery of healthcare in this era of accountable care, which includes the important concepts of patient-centered care and coordinated care. This also includes effective utilization and interpretation of laboratory testing, the use of laboratory data to manage patient populations and determining the efficacy of the clinical management of patients as driven by critical laboratory values.

Northwell Health’s clinical laboratories provide diagnostic services to over 1.6 million patients each year, and more than 16 million laboratory tests are performed system wide. In essence, the clinical laboratories influence the clinical management of almost every patient receiving care from the health system. In turn, the data residing within the laboratory data record has the potential for immense value in providing more effective and timely healthcare.

Dr. Crawford has also been a reference pathologist collaborator at the national level for the use of optical imaging and in vivo microscopy for the early diagnosis of dysplasia and cancer of the upper and lower alimentary tract. In addition, he has served as a pathologist collaborator for the national effort to advance implementation of the “patient-centered medical home.


Dartmouth College, Hanover NH
Degree: BA
Field of Study: Chemistry

Duke University Sch. Of Med., Durham, NC
Degree: MD
Field of Study: Medicine

Duke University Grad. Sch., Durham, NC
Degree: PhD
Field of Study: Physiology

Awards & Honors

1972-1975 Dartmouth College: Summa Cum Laude; Highest Honors in Chemistry; Phi Beta Kappa; Churchill Outstanding Freshman Prize; Richardson Freshman Chemis¬try Prize; Towne Sophomore Science Prize; Barrett Senior Overall Achievement Prize; Outstanding Skier and Outstanding Skier-Scholar Prizes; Dartmouth Rowing Hall of Fame.
1976-1982 Duke University Medical and Graduate School: Alpha Omega Alpha and Sigma Xi Honor Societies; Medical Scientist Training Award.
1989 Burroughs Welcome Research Scholar in Hepatic Pathology, Royal Free Hospital, London, England.
1999-2008 NIDDK Study Section GMA-2, NIDDK Section GMA-3, NIDDK Hepatobiliary & Pancreatic Disease Study Section, NIH special study sections (NINDS, NHLBI, NIDDK, NICAM)
2000-2008 President, Florida Clinical Practice Association (the faculty practice organization); Chair, Executive Fiscal Advisory Committee, University of Florida College of Medicine
2003-2008 Editor-in-Chief, Laboratory Investigation
2004-2008 President-elect (2004-2006), President (2006-2008), Past-President (2008-2010), Association of Pathology Chairs (APC)
2005-2007 President, Hans Popper Hepatopathology Society
2004-present College of American Pathologists (CAP) (2004-2008); Chair, PathPAC Board of Directors (Political Action Committee) (2004-2008); member, Council on Government and Professional Affairs (2010); member, Health IT and Personalized Medicine Committee
2004-present National Cancer Institute (2004-2009); Network for Translational Research in Optical Imaging; Chair, Pathology Working Group; Co-Chair, Validation and Clinical Trials Core (2009-present)
2005-present Association of American Medical Colleges (AAMC) (2005-2012); member, Council of Academic Societies (CAS) Administrative Board (2007-2008); member, AAMC Executive Council (2009-2010); Chair-elect, CAS (2010-2011); Chair, CAS (2009-2011); member, AAMC Board of Directors
2006 Gold Medal Award, International Academy of Pathology
2008-present Co-Chair, Center for eHealth Information Exchange and Adoption (CeHIA), Patient Centered Primary Care Collaborative (pcpcc.net)
2009-present Biomedical Research Alliance of New York, Vice Chair, Managing Committee
2009 Resident Advocacy Award, College of American Pathology
2010 F.K. Mostofi Distinguished Service Award, United States and Canadian Academy of Pathology

  1. Nace D, Crawford J, Marchibroda J, Nohrden C, and Health2Resources. 2009. “Meaningful Connections – The Patient-Centered Medical Home: Center for Health Information Technology and Exchange (CeHIA) Resource Guide.”  The Patient Centered Primary Care Collaborative (www.pcpcc.net).
  2. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, Lotlikar M, Kowerska M, Becker G, Korologos D, de Geronimo M, Crawford JM. (2009). “Evaluation of multiple test methods for the detection of the novel 2009 Influenza A (H1N1) during the New York City outbreak.” J Clin Virol 45: 146-149.
  3. Crawford JM, Stallone R, Zhang F, Gerolimatos M, Korologos DD, Sweetapple C, de Geronimo M, Dlugacz Y, Armellino DM, Ginocchio CC. (2010). “Laboratory surge response to the novel influenza A H1N1 outbreak in the New York City metropolitan area.” Emerging Infectious Diseases 16: 8-13.
  4. Crawford JM, Hoffman RD, Black-Schaffer WS. (2011). “Pathology subspecialty fellowship application reform.” 2007-2010. Am J Clin Pathol 135: 338-356 (with editorial comment); simultaneous publications.
  5. Liu JTC, Loewke NO, Mandella MJ, Levenson RM, Crawford JM, Contag CH. (2011). “Point-of-care pathology with miniature microscopes.” Analytical Cellular Pathology 34: 81-98.
  6. Hytiroglou P, Alves V, Balabaud C, Bhathal P, Bioulac-Sage P, Crawford JM, Dhillon AP, Ferrell LD, Guido M, Nakanuma Y, Paradis V, Quaglia A, Theise ND, Thung SN, Tsui MS, van Leeuwen DJ, Snover D.  (2012). “Beyond cirrhosis: a proposal from the International Liver Pathology Study Group.” Am J Clin Pathol 137: 5-9.
  7. Crawford JM. 2011. “Use of Information Systems to Support Coordination of Care. In Role of Care Coordination in the Context of the Patient Centered Medical Home.”  Health2Resources, White Paper for The Patient Centered Primary Care Collaborative (www.pcpcc.net ).
  8. Crawford JM, Aspinall MG. (2012). “Business Value and Cost Effectiveness of Genomic Medicine.” Personalized Medicine 9: 265-286.

View more at PubMed